Loading…
← CockpitCompetitor Analysis › JUBLINGREA.NS Jubilant IngreviaOpen in the cockpit ↗

Jubilant IngreviaJUBLINGREA.NSCompetitor analysis, valuation and peers

India · INR·Chemicals›Chemicals: Major Diversified

Specialty chemicals/pyridine-chemistry maker (demerged from Jubilant Life Sciences) supplying agrochemical and nutrition ingredients.

Momentum laggard 12
Mkt cap
$1.00B
US dollars, full cap
Free float
50%
of shares outstanding
$/day
$3.45M
20-day average traded
Fwd P/E
21.6×
forward earnings
ROIC−WACC
-6.0 pp
WACC 15.4%
Hurdle
-17 pp
Req g minus delivered
Next earnings
76 days
2 Feb 2027
Close · INR₹586.85
1D-0.3%
1W-2.1%
1M-5.9%
3M-19.2%
6M-19.2%
YTD-16.6%
1Y-12.9%
ATR %3.4%
Beta1.16
52w lowhigh26.2% off high

What Jubilant Ingrevia does

Specialty chemicals/pyridine-chemistry maker (demerged from Jubilant Life Sciences) supplying agrochemical and nutrition ingredients.

Makes pyridine-based chemicals sold into agrochemical, nutrition and pharma uses, so profit depends on the price gap against Chinese and European competitors. It was split off from Jubilant Life Sciences in 2021 and belongs to the Jubilant Bhartia group.

Products and services

  • Agrochemical intermediates
  • Nutrition ingredients (Vitamin B3/niacinamide)
  • Life-science chemicals/CDMO

Customers

  • Agrochemical companies
  • Animal feed/nutrition companies
  • Pharma companies (CDMO)

Where it sits in the supply chain

  • Specialty chemicals
  • Pyridine/agrochemical & nutrition…
  • Life-science ingredients & CDMO

What could go right

  • Global demand for niacinamide/pyridine derivatives
  • CDMO contract growth

What could go wrong

  • Chinese pyridine-chemical price competition
  • Cyclical agrochemical demand

Moat: narrow (scale, process know-how). One of the world's largest pyridine-chemistry producers, but Chinese and European rivals compete on price.

Headquarters: Noida, India · Founded: 2020 · Employees: 3,429

Named competitors

Jubilant Ingrevia at a glance

Size Jubilant Ingrevia (JUBLINGREA.NS) is an India Materials company (Chemicals: Major Diversified) with a market value of $1.00B, the 600th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹586.85 on 18 Nov 2026.

Performance Over six months the shares fell 19.2%, against -26.9% for the median peer and +3.8% for the India market (cap-weighted) — 9th highest of 21 in its peer set.

Growth Revenue grew 15.4% over the last twelve months (peer median +2.5%); the operating margin is 10.3% (peer median 11.1%).

Valuation It trades at 21.6× forward earnings against a peer median of 21.7× (7th cheapest of 14).

Price implies For today's price to make sense, revenue must grow about 28% a year for seven years (Req g). Recent delivered growth is +45%, so the hurdle is -17 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 6.0 points below its cost of capital (15.4% WACC).

Next results Next results expected around 2 Feb 2027 (exchange calendar; dates can move).

Relative performance

809010021 May 202621 Aug 202618 Nov 2026JUBLINGREA.NS 80Peer median 74
Six months, rebased to 100: Jubilant Ingrevia against the median of its 20 peers (local-currency closes).

Jubilant Ingrevia financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹49.2B₹43.6B₹41.6B₹41.2B₹47.7B
Revenue growth—+5%+1%-14%—
Gross profit₹12.8B₹8.08B₹7.63B₹6.90B₹7.62B
EBITDA₹7.01B₹5.74B₹5.24B₹4.36B₹5.67B
Net income₹3.51B₹2.78B₹2.51B₹1.83B₹3.07B
Free cash flown/a₹1.63B₹729M-₹2.05B-₹618M
Capital expendituren/a₹2.99B₹3.66B₹5.68B₹4.81B
Total debt₹8.95B₹7.92B₹7.64B₹7.40B₹4.07B

Quarterly statements and history in the cockpit →

Jubilant Ingrevia competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%2143706033607666VCTRPEL3007793006416032006003286031814763603281LXS68835960315544713013930025854041JUBLINGREA.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Jubilant Ingrevia is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%0×50×100×214370603360300779603181476360328100042060315544713013930025854041JUBLINGREA.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Jubilant Ingrevia is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%-20%0%20%40%214370603360VCT3006414763603281LXS60315544714041JUBLINGREA.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Jubilant Ingrevia is the large dot.

Jubilant Ingrevia competitors and peer comparison

Head to head with its named competitors (JUBLINGREA.NS vs LONN.SW vs DSFIR.AS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Jubilant Ingrevia JUBLINGREA.NS$1.00B-19%+15%10%21.6×28.0%
Lonza LONN.SW$53.9B+36%-11%25%36.1×15.6%
DSM-Firmenich DSFIR.AS$27.5B+47%-45%8%28.6×23.7%

How Jubilant Ingrevia compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Jubilant Ingrevia against its 20 peers (data as of 18 Nov 2026)
MeasureJUBLINGREA.NSPeer medianRank in peer set
1-month return-5.9%-15.0%6th highest of 21
6-month return-19.2%-26.9%9th highest of 21
Distance from 52-week high-26.2%-47.1%5th highest of 21
Revenue growth (TTM)+15.4%+2.5%5th highest of 21
Operating margin10.3%11.1%10th lowest of 21
Forward P/E21.6×21.7×7th cheapest of 14
Growth the price implies (Req g, 7 yrs)28.0%7.1%2nd most demanding of 12
Growth delivered (Del g)+44.9%+3.8%highest of 12
Hurdle (Req g minus delivered)-16.9 pp+3.5 pp2nd least demanding of 12
ROIC minus cost of capital-6.0 pp-1.8 pp5th lowest of 21
EV / EBITDA14.3×9.8×3rd most expensive of 8
Net debt / EBITDA1.0×-0.3×3rd most indebted of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Jubilant Ingrevia JUBLINGREA.NSIndia$1.00B-19%+15%10%21.6×28.0%+44.9%
Caregen 214370.KSSouth Korea$982M-74%-2%20%21.5×36.8%+3.8%
Dalian Bio-Chem 603360.SSChina$971M-54%0%16%21.7×8.5%+18.4%
Metis TechBio 7666.HKHong Kong$1.05B-64%+6,987%-367%n/an/an/a
Victrex VCT.LUnited Kingdom$1.06B+46%-1%14%22.5×16.7%+1.9%
Raghav Productivity Enhancers RPEL.NSIndia$942M+109%+38%28%n/an/an/a
Qingdao Huicheng Environmental Technology 300779.SZChina$1.08B-48%-13%5%69.5×n/an/a
Jiangsu Zhengdan Chemical Industry 300641.SZChina$914M-29%-30%17%n/a7.1%+11.6%
Shanghai Emperor of Cleaning Hi-Tech 603200.SSChina$1.12B-24%+4%-8%n/an/an/a
CNSIG Inner Mongolia Chemical Industry 600328.SSChina$1.12B-36%-20%-7%n/an/an/a
Zhejiang Huangma Technology 603181.SSChina$891M-33%+7%17%13.8×n/an/a
Jinan Acetate Chemical 4763.TWTaiwan$1.14B-5%-24%43%6.6×-20.2%+41.2%
Hubei Jianghan New Materials 603281.SSChina$1.15B-38%+8%17%21.1×3.9%+6.3%
Lanxess LXS.DEGermany$1.19B-24%-4%0%n/a5.3%-1.5%
Jilin Chemical Fibre Stock 000420.SZChina$1.20B-34%+11%5%130.4×n/an/a
Guangzhou Sanfu Newmaterials Technology 688359.SSChina$832M-54%+8%-7%n/an/an/a
Xinyaqiang Silicon Chemistry 603155.SSChina$798M-15%+25%12%37.4×22.5%+3.9%
Sanyo Chemical Industries 4471.TJapan$794M+8%+8%11%9.6×-7.2%-2.5%
Suzhou Highfine Biotech 301393.SZChina$786M-15%+36%17%29.4×n/an/a
Jiangsu Shuangxing Color Plastic New Materials 002585.SZChina$1.27B-10%-4%-4%57.9×21.0%+0.2%
Nippon Soda 4041.TJapan$1.29B+11%0%10%12.2×5.2%+1.8%

Questions

Who are Jubilant Ingrevia's main competitors?
Named competitors: Lonza (LONN.SW), DSM-Firmenich (DSFIR.AS), Chinese pyridine producers (private or unlisted). The cockpit's measured peer set (industry) also includes Caregen (214370.KS), Dalian Bio-Chem (603360.SS), Metis TechBio (7666.HK), Victrex (VCT.L), Raghav Productivity Enhancers (RPEL.NS), Qingdao Huicheng Environmental Technology (300779.SZ).
Is Jubilant Ingrevia expensive compared with its peers?
On forward p/e it trades at 21.6× against a peer median of 21.7×, 7th cheapest of 14 in its peer set. For today's price to make sense, revenue must grow about 28% a year for seven years (Req g). Recent delivered growth is +45%, so the hurdle is -17 pp: the price already allows for a slowdown.
How has Jubilant Ingrevia stock performed?
Over six months to 18 Nov 2026 the shares returned -19.2% against -26.9% for the median peer; over one year -12.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.